<DOC>
	<DOCNO>NCT01738815</DOCNO>
	<brief_summary>The goal study test whether drug valproic acid cause change bladder tumor might inhibit growth .</brief_summary>
	<brief_title>Impact Valproate Angiogenesis Histone Deacetylation Bladder Cancer</brief_title>
	<detailed_description>Bladder cancer fourth common cancer United States 60,000 new case year . It usually treat initially insertion endoscope bladder surgically remove tumor , procedure know cystoscopy trans-urethral resection bladder tumor ( TURBT ) . For patient procedure successfully remove detectable tumor . Unfortunately 40 % patient develop cancer recurrence less two year patient remain increased risk recurrence remainder live . This risk require life long monitoring best accomplished regular cystoscopic examination . The goal study test whether drug valproic acid cause change bladder tumor might inhibit growth . Patients suspected bladder cancer invite participate study , tumor observe cystoscopy sample research purpose accord standard care , patient schedule TURBT general anesthesia . In interval discovery bladder tumor resection , usually two four week , patient give valproic acid take orally . In addition , tumor patient know suspected bladder cancer refer TURBT cystectomy sample . The tumor piece obtain take valproic acid referral patient treat valproic acid analyze see drug change gene active . We find valproic acid cause bladder cancer cell make protein , thrombospondin-1 . This protein inhibit growth new blood vessel increase thrombospondin-1 bladder tumor inhibit growth decrease blood supply . Valproic acid may change thrombospondin-1 level inhibition histone deacetylases . We also assay HDAC activity tumor specimen . If valproic acid alters thrombospondin-1 level HDAC activity bladder cancer patient study see reduce growth justified . Valproic acid drug approve treatment seizure disorder generally well tolerated side effect . It may prove useful reduce bladder cancer recurrence progression .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Hematuria</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>1 . Patient age 21 2 . Bladder tumor suspect confirm 3 . ECOG status 0 2 4 . Premedication Lab value : Absolute Neutrophil Count &gt; 750 cells/m3 AST/ALT le 1.5xN Amylase less 1.5xN Platelet Count &gt; 125,000 PT/PTT &gt; 1.3xN Hemoglobin &gt; 8gm/dL Creatinine less 1.5xN 1 . Allergy valproic acid 2 . Concurrent chemotherapy 3 . Premenopausal woman 4 . Active systemic infection ( HepatitisB , C ) 5 . Coagulation disorder 6 . Concurrent medication : Tolbutamide , Warfarin , Zidovudine , Benzodiazepine , Clonazepam , Diazepam , Any anticonvulsant therapy 7 . Seizure disorder 8 . Dementia 9 . History Pancreatitis 10 . HIV diagnosis/treatment 11 . Liver disease/dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>bladder cancer</keyword>
	<keyword>hematuria</keyword>
	<keyword>sodium valproate</keyword>
	<keyword>valproic acid</keyword>
</DOC>